genes Greer’s SLIT tablet for HDM-induced allergic rhinitis is already commercialised in 21 countries and territories with more to follow under the brand names Actair®, Orylmyte®or Aitmyte®.

With this agreement, Stallergenes Greer continues to advance its mission of improving allergy care by making immunotherapy treatments accessible in new and high-need markets.

ABOUT ALLERGIC RHINITIS

Allergic rhinitis is a worldwide disease estimated to affect around 400 to 500 million peopleii,iii, who are at higher risk of developing rhinitis exacerbation and asthma than the general population. Allergic rhinitis can include symptoms such as sneezing, a runny or itchy nose, nasal congestion and watery or itchy eyes, among others. Symptoms may be severe and can worsen over time and have a significant impact on quality of life.

ABOUT NUANCE PHARMA

Nuance Pharma is an innovation focused biopharmaceutical company, with both late-stage
=*=*=*=*=*=
当前为第4/6页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页